Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |